References
- Burkhart PV, Sabaté E. Adherence to long-term therapies: evidence for action. J Nurs Scholarsh 2003;35(3):207.
- Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clin Proc 2011;86(4):304–14.
- De Mauri A, Carrera D, Vidali M, et al. Compliance, adherence and concordance differently predict the improvement of uremic and microbial toxins in chronic kidney disease on low protein diet. Nutrients 2022;14(3).
- Riegel B, Dickson VV. A qualitative secondary data analysis of intentional and unintentional medication nonadherence in adults with chronic heart failure. Heart Lung 2016;45(6):468–74.
- Altamimi AF, Alqahtani ZA, Almughaiseeb FA, et al. The attitude and prevalence of patient noncompliance toward chronic disease medications in Saudi Arabia. J Family Med Prim Care 2021;10(8):3064–70.
- Jimmy B, Jose J. Patient medication adherence: measures in daily practice. Oman Med J 2011;26(3):155–9.
- Atinga RA, Yarney L, Gavu NM. Factors influencing long-term medication non-adherence among diabetes and hypertensive patients in Ghana: a qualitative investigation. PLoS One 2018;13(3):e0193995.
- Peh KQE, Kwan YH, Goh H, et al. An adaptable framework for factors contributing to medication adherence: results from a systematic review of 102 conceptual frameworks. Journal of Gen Int Med 2021;36(9):2784–95.
- World Health Organization. Adherence to long-term therapies:evidence for action. Geneva: WHO; 2003.
- Government of Western Australia Department of Health. Guiding principles for timely administration of medications. 2020. At: www.health.wa.gov.au/~/media/Files/Corporate/Policy-Frameworks/Clinical-Governance-Safety-and-Quality/Policy/High-Risk-Medication-Policy/Supporting/Guiding-Principles-for-Timely-Administration-of-Medications.pdf
- Yu JRT, Sokola BS, Walter BL. Optimization of inpatient medication administration among persons with Parkinson’s disease: recommendations on pharmacy technology and workflow. Front Pharmacol 2023;14:1254757.
- Rossi S, ed. Other drugs for Parkinson’s disease. Adelaide: Australian Medicines Handbook Pty Ltd; 2024.
- Anderson E, Prior F. Which medicines are ‘time-critical’? The Society of Hospital Pharmacists of Australia 2020;2(1).
- Gilbert A, Roughead L, Sansom L. I’ve missed a dose; what should I do? Australian prescriber 2002;25(1):16–8.
- Hallare J, Gerriets V. Half Life. StatPearls. Treasure Island (FL): StatPearls Publishing; 2024.
- Warner CH, Bobo W, Warner C, et al. Antidepressant discontinuation syndrome. Am Fam Physician. 2006;74(3):449–56.
- Albassam A, Hughes DA. What should patients do if they miss a dose? A systematic review of patient information leaflets and summaries of product characteristics. Eur J Clin Pharmacol 2021;77(2):251–60.
- Sansom LN, ed. Australian pharmaceutical formulary and handbook. 26th edn. Canberra:Pharmaceutical Society of Australia;2024.
- NPS MedicineWise. Consumer medicine information (CMI) explained. 2018. At: www.nps.org.au
- Healthdirect. How to read Consumer Medicine Information (CMI). 2022. At: www.healthdirect.gov.au
- Specialist Pharmacy Service. Advising on missed or delayed doses of medicines. 2023. At: www.sps.nhs.uk/articles/advising-on-missed-or-delayed-doses-of-medicines/
- Actonel Once-a-month tablets. Consumer Medicines Information. eMIMS Plus Cloud [2024] At: www.emims.com.au/drug/search